申请人:Warner-Lambert Company
公开号:US05760050A1
公开(公告)日:1998-06-02
1,2,3,4-Tetrahydro-chromeno\x9b3,4-c!pyridin-5-ones of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, and R.sub.5 include hydrogen, alkyl, alkoxy, hydroxy, halo, nitro, amino, and trifluoromethyl; R.sub.4 is unsubstituted or substituted phenyl, pyridyl, or quinolinyl; and n is 0 to 4, are useful to treat psychosis in mammals, particularly schizophrenia.
公式为 ##STR1## 的1,2,3,4-四氢-香豆素\x9b3,4-c!吡啶-5-酮化合物,在其中R.sub.1,R.sub.2,R.sub.3和R.sub.5包括氢,烷基,烷氧基,羟基,卤素,硝基,氨基和三氟甲基; R.sub.4未取代或被取代的苯基,吡啶基或喹啉基; n为0至4,适用于治疗哺乳动物的精神病,尤其是精神分裂症。